Related Experiment Videos
Radiological work-up in Peutz-Jeghers syndrome
Sebuh Kurugoglu1, Hilmi Aksoy, Fatih Kantarci
1Department of Radiology, Cerrahpasa Medical Faculty, Istanbul University, 34300, Istanbul, Turkey. sebuh.k@superonline.com
Pediatric Radiology
|September 26, 2003
Summary
Radiological contrast studies, MRI, and ultrasound (US) were compared for Peutz-Jeghers syndrome (PJS) patients. MRI and contrast studies effectively detected polyps, while US had lower sensitivity, highlighting imaging options for PJS surveillance.
Area of Science:
- Gastroenterology
- Medical Imaging
- Genetics
Background:
- Modern imaging techniques like high-resolution ultrasound (US) and magnetic resonance imaging (MRI) are increasingly used for gastrointestinal tract examinations.
- Peutz-Jeghers syndrome (PJS) is a genetic disorder characterized by hamartomatous polyps in the gastrointestinal tract and an increased risk of malignancies.
Purpose of the Study:
- To compare the efficacy of radiological contrast studies, US, and MRI in evaluating patients with Peutz-Jeghers syndrome (PJS).
- To assess the diagnostic performance of different imaging modalities for detecting polyps and other abnormalities in PJS.
Main Methods:
- Ten members from two families with PJS were evaluated.
- Patients were categorized into three groups based on perioral pigmentations and clinical symptoms.
- Imaging examinations included US, MRI, and radiological contrast studies.
Main Results:
- Contrast studies and MRI successfully identified polyps in all evaluated PJS patients (n=7).
- Ultrasound (US) detected polyps in only three out of six patients.
- No evidence of malignant transformation was observed in any of the imaging studies; intussusception was also noted.
Conclusions:
- While contrast studies are the gold standard for PJS polyp detection, MRI is a viable alternative.
- US demonstrated lower sensitivity for polyp detection in this PJS cohort.
- Regular radiological follow-up using MRI or US is recommended for adult PJS patients to monitor for malignancies without cumulative radiation exposure.